Page 3 - Recent Updates News Today

Peter Martin, MD, discusses how to sequence bispecific T-cell engagers and CAR T-cell therapies in the third-line and beyond setting for FL.

After some investigation, I found an easy fix to this perplexing Windows error.

Laurie Sehn, MD, discusses recent data on zanubrutinib, a BTK inhibitor, as third-line and beyond therapy for FL.

A panel of experts discuss how to choose bispecific T-cell engagers as third-line and beyond therapy for FL.

You’ve probably found yourself perplexed by a Pinterest 405 error, wondering why it decided to make an appearance just when you were immersed in the world of pins and boards. It’s not uncommon, and the frustration it brings can be overwhelming. Our goal is to bring you the solution to the Pinterest 405 error so […]

Supply constraints for the artificial intelligence (AI) hardware market are expected to continue in 2024, which could be good news for AI chip investors.

Nvidia is confident that it can grow revenue in 2024 and 2025.

Matthew Lunning, DO, discusses recent data on bispecific T-cell engagers as third-line and beyond therapy for FL.

Peter Martin, MD, discusses recent data on tazemetostat, an EZH2 inhibitor, as third-line and beyond therapy for FL.

Mobileye is not the only semiconductor stock to give a weaker-than-expected outlook.